TY - JOUR AU - Littlejohn, E. A. AU - Monrad, S. U. PY - 2018 DA - 2018// TI - Early diagnosis and treatment of rheumatoid arthritis JO - Prim Care VL - 45 UR - https://doi.org/10.1016/j.pop.2018.02.010 DO - 10.1016/j.pop.2018.02.010 ID - Littlejohn2018 ER - TY - JOUR AU - Hyrich, K. L. AU - Watson, K. D. AU - Silman, A. J. AU - Symmons, D. P. PY - 2006 DA - 2006// TI - Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register JO - Rheumatology (Oxford) VL - 45 UR - https://doi.org/10.1093/rheumatology/kel149 DO - 10.1093/rheumatology/kel149 ID - Hyrich2006 ER - TY - JOUR AU - Wijbrandts, C. A. AU - Tak, P. P. PY - 2017 DA - 2017// TI - Prediction of response to targeted treatment in rheumatoid arthritis JO - Mayo Clin Proc. VL - 92 UR - https://doi.org/10.1016/j.mayocp.2017.05.009 DO - 10.1016/j.mayocp.2017.05.009 ID - Wijbrandts2017 ER - TY - JOUR AU - Cherlin, S. AU - Plant, D. AU - Taylor, J. C. AU - Colombo, M. AU - Spiliopoulou, A. AU - Tzanis, E. PY - 2018 DA - 2018// TI - Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data JO - Genet Epidemiol VL - 42 UR - https://doi.org/10.1002/gepi.22159 DO - 10.1002/gepi.22159 ID - Cherlin2018 ER - TY - JOUR AU - Bluett, J. AU - Barton, A. PY - 2017 DA - 2017// TI - Precision medicine in rheumatoid arthritis JO - Rheum Dis Clin North Am VL - 43 UR - https://doi.org/10.1016/j.rdc.2017.04.008 DO - 10.1016/j.rdc.2017.04.008 ID - Bluett2017 ER - TY - JOUR AU - Viatte, S. AU - Barton, A. PY - 2017 DA - 2017// TI - Genetics of rheumatoid arthritis susceptibility, severity, and treatment response JO - Semin Immunopathol. VL - 39 UR - https://doi.org/10.1007/s00281-017-0630-4 DO - 10.1007/s00281-017-0630-4 ID - Viatte2017 ER - TY - JOUR AU - Her, M. AU - Kavanaugh, A. PY - 2016 DA - 2016// TI - Alterations in immune function with biologic therapies for autoimmune disease JO - J Allergy Clin Immunol. VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.10.023 DO - 10.1016/j.jaci.2015.10.023 ID - Her2016 ER - TY - JOUR AU - Smolen, J. S. AU - Landewe, R. AU - Breedveld, F. C. AU - Buch, M. AU - Burmester, G. AU - Dougados, M. PY - 2014 DA - 2014// TI - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-204573 DO - 10.1136/annrheumdis-2013-204573 ID - Smolen2014 ER - TY - JOUR AU - Turner, M. D. AU - Nedjai, B. AU - Hurst, T. AU - Pennington, D. J. PY - 2014 DA - 2014// TI - Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease JO - Biochim Biophys Acta VL - 1843 UR - https://doi.org/10.1016/j.bbamcr.2014.05.014 DO - 10.1016/j.bbamcr.2014.05.014 ID - Turner2014 ER - TY - JOUR AU - McGonagle, D. AU - McDermott, M. F. PY - 2006 DA - 2006// TI - A proposed classification of the immunological diseases JO - PLoS Med. VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030297 DO - 10.1371/journal.pmed.0030297 ID - McGonagle2006 ER - TY - JOUR AU - Alenius, G. M. AU - Eriksson, C. AU - Rantapaa, D. a. h. l. q. v. i. s. t. S. PY - 2009 DA - 2009// TI - Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? JO - Clin Exp Rheumatol VL - 27 ID - Alenius2009 ER - TY - JOUR AU - Costa, L. AU - Caso, F. AU - Cantarini, L. AU - Puente, A. AU - Scarpa, R. AU - Atteno, M. PY - 2014 DA - 2014// TI - Efficacy of tocilizumab in a patient with refractory psoriatic arthritis JO - Clin Rheumatol VL - 33 UR - https://doi.org/10.1007/s10067-014-2603-5 DO - 10.1007/s10067-014-2603-5 ID - Costa2014 ER - TY - JOUR AU - FitzGerald, O. PY - 2016 DA - 2016// TI - Spondyloarthropathies: IL-6 blockade in psoriatic arthritis—a new therapeutic option? JO - Nat Rev Rheumatol VL - 12 UR - https://doi.org/10.1038/nrrheum.2016.84 DO - 10.1038/nrrheum.2016.84 ID - FitzGerald2016 ER - TY - JOUR AU - Mease, P. J. AU - Gottlieb, A. B. AU - Berman, A. AU - Drescher, E. AU - Xing, J. AU - Wong, R. PY - 2016 DA - 2016// TI - The efficacy and safety of clazakizumab, an anti-interleukin-6 monoclonal antibody, in a phase IIb study of adults with active psoriatic arthritis JO - Arthritis Rheumatol. VL - 68 UR - https://doi.org/10.1002/art.39700 DO - 10.1002/art.39700 ID - Mease2016 ER - TY - JOUR AU - Kuijk, A. W. AU - Reinders-Blankert, P. AU - Smeets, T. J. AU - Dijkmans, B. A. AU - Tak, A. A. PY - 2006 DA - 2006// TI - Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment JO - Ann Rheum Dis. VL - 65 UR - https://doi.org/10.1136/ard.2005.050963 DO - 10.1136/ard.2005.050963 ID - Kuijk2006 ER - TY - JOUR AU - Zhou, Q. AU - Wang, H. AU - Schwartz, D. M. AU - Stoffels, M. AU - Park, Y. H. AU - Zhang, Y. PY - 2016 DA - 2016// TI - Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease JO - Nat Genet VL - 48 UR - https://doi.org/10.1038/ng.3459 DO - 10.1038/ng.3459 ID - Zhou2016 ER - TY - JOUR AU - Cubino, N. AU - Montilla, C. AU - Usategui-Martin, R. AU - Cieza-Borrela, C. AU - Carranco, T. AU - Calero-Paniagua, I. PY - 2016 DA - 2016// TI - Association of IL1Beta (-511 A/C) and IL6 (− 174 G>C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis JO - Clin Rheumatol VL - 35 UR - https://doi.org/10.1007/s10067-016-3301-2 DO - 10.1007/s10067-016-3301-2 ID - Cubino2016 ER - TY - JOUR AU - Terry, C. F. AU - Loukaci, V. AU - Green, F. R. PY - 2000 DA - 2000// TI - Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M000379200 DO - 10.1074/jbc.M000379200 ID - Terry2000 ER - TY - JOUR AU - Ellinghaus, E. AU - Ellinghaus, D. AU - Stuart, P. E. AU - Nair, R. P. AU - Debrus, S. AU - Raelson, J. V. PY - 2010 DA - 2010// TI - Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 JO - Nat Genet VL - 42 UR - https://doi.org/10.1038/ng.689 DO - 10.1038/ng.689 ID - Ellinghaus2010 ER - TY - JOUR AU - Huffmeier, U. AU - Uebe, S. AU - Ekici, A. B. AU - Bowes, J. AU - Giardina, E. AU - Korendowych, E. PY - 2010 DA - 2010// TI - Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis JO - Nat Genet VL - 42 UR - https://doi.org/10.1038/ng.688 DO - 10.1038/ng.688 ID - Huffmeier2010 ER - TY - JOUR AU - Bulek, K. AU - Liu, C. AU - Swaidani, S. AU - Wang, L. AU - Page, R. C. AU - Gulen, M. F. PY - 2011 DA - 2011// TI - The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation JO - Nat Immunol VL - 12 UR - https://doi.org/10.1038/ni.2080 DO - 10.1038/ni.2080 ID - Bulek2011 ER - TY - JOUR AU - Sun, D. AU - Novotny, M. AU - Bulek, K. AU - Liu, C. AU - Li, X. AU - Hamilton, T. PY - 2011 DA - 2011// TI - Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) JO - Nat Immunol VL - 12 UR - https://doi.org/10.1038/ni.2081 DO - 10.1038/ni.2081 ID - Sun2011 ER - TY - JOUR AU - Ganesan, R. AU - Rasool, M. PY - 2017 DA - 2017// TI - Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions JO - Int Rev Immunol VL - 36 UR - https://doi.org/10.1080/08830185.2016.1269175 DO - 10.1080/08830185.2016.1269175 ID - Ganesan2017 ER - TY - JOUR AU - Danis, J. AU - Janovak, L. AU - Guban, B. AU - Goblos, A. AU - Szabo, K. AU - Kemeny, L. PY - 2018 DA - 2018// TI - Differential inflammatory-response kinetics of human keratinocytes upon cytosolic RNA- and DNA-fragment induction JO - Int J Mol Sci. VL - 19 UR - https://doi.org/10.3390/ijms19030774 DO - 10.3390/ijms19030774 ID - Danis2018 ER - TY - JOUR AU - Mensah, K. A. AU - Schwarz, E. M. AU - Ritchlin, C. T. PY - 2008 DA - 2008// TI - Altered bone remodeling in psoriatic arthritis JO - Curr Rheumatol Rep VL - 10 UR - https://doi.org/10.1007/s11926-008-0050-5 DO - 10.1007/s11926-008-0050-5 ID - Mensah2008 ER - TY - JOUR AU - Veale, D. J. AU - Fearon, U. PY - 2018 DA - 2018// TI - The pathogenesis of psoriatic arthritis JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30830-4 DO - 10.1016/S0140-6736(18)30830-4 ID - Veale2018 ER - TY - JOUR AU - Amos, P. J. AU - Cagavi Bozkulak, E. AU - Qyang, Y. PY - 2012 DA - 2012// TI - Methods of cell purification: a critical juncture for laboratory research and translational science JO - Cells Tissues Organs. VL - 195 UR - https://doi.org/10.1159/000331390 DO - 10.1159/000331390 ID - Amos2012 ER - TY - JOUR AU - Matsushima, Y. AU - Kikkawa, Y. AU - Takada, T. AU - Matsuoka, K. AU - Seki, Y. AU - Yoshida, H. PY - 2010 DA - 2010// TI - An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene JO - J Immunol. VL - 185 UR - https://doi.org/10.4049/jimmunol.0900694 DO - 10.4049/jimmunol.0900694 ID - Matsushima2010 ER - TY - JOUR AU - Das, N. A. AU - Carpenter, A. J. AU - Yoshida, T. AU - Kumar, S. A. AU - Gautam, S. AU - Mostany, R. PY - 2018 DA - 2018// TI - TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart JO - J Mol Cell Cardiol VL - 121 UR - https://doi.org/10.1016/j.yjmcc.2018.07.003 DO - 10.1016/j.yjmcc.2018.07.003 ID - Das2018 ER -